PuraPharm Corporation Limited (HKG:1498)

Revenue by Segment

Financials in millions HKD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Hong Kong CCMG	204.95M	212.49M	215.47M	199.41M	170.64M
Hong Kong CCMG Growth	-3.55%	-1.38%	8.06%	16.86%	10.57%
Chinese Healthcare Products	96.97M	85.91M	83.58M	79.28M	79.09M
Chinese Healthcare Products Growth	12.88%	2.78%	5.44%	0.23%	-9.10%
Clinics	51.24M	56.31M	53.73M	46.11M	50.03M
Clinics Growth	-9.01%	4.81%	16.51%	-7.83%	0.21%
Plantation	175.97M	183.98M	37.61M	89.53M	44.83M
Plantation Growth	-4.35%	389.17%	-57.99%	99.72%	2.31%
Elimination	-193.01M	-156.59M	-156.33M	-208.51M	-136.05M
China CCMG	-	-	172.80M	242.25M	451.05M
China CCMG Growth	-	-	-28.67%	-46.29%	28.68%
Total	336.11M	382.09M	406.86M	448.07M	659.59M
Total Growth	-12.03%	-6.09%	-9.20%	-32.07%	9.60%

Revenue by Geography

Financials in millions HKD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Hong Kong	291.82M	305.52M	305.28M	281.53M	242.48M
Hong Kong Growth	-4.49%	0.08%	8.44%	16.11%	6.39%
Mainland China	2.61M	35.32M	62.87M	132.30M	374.09M
Mainland China Growth	-92.61%	-43.81%	-52.48%	-64.63%	15.70%
Other Countries/Regions	41.69M	41.24M	38.71M	34.24M	43.03M
Other Countries/Regions Growth	1.07%	6.54%	13.06%	-20.43%	-14.89%
Total	336.11M	382.09M	406.86M	448.07M	659.59M
Total Growth	-12.03%	-6.09%	-9.20%	-32.07%	9.60%

Source: S&P Global Market Intelligence.